Sanjay Ramakrishnan (@sanjayresp) 's Twitter Profile
Sanjay Ramakrishnan

@sanjayresp

Academic Respiratory Physician @Charlies_Resp & @Resp_Health | Senior Lecturer @uwanews | #NewPI #COPD #Asthma 🇦🇺 🇲🇾

ID: 230117480

calendar_today24-12-2010 09:43:09

1,1K Tweet

1,1K Followers

1,1K Following

Peter Wark (@peterwark1710) 's Twitter Profile Photo

ABRA trial for people with eosinophilia acute asthma or COPD a single dose of benralizumab was superior to prednisone preventing treatment failure Odds ratio 0.26 95%ci 0.125, 0.57 #ers2024 Mona Bafadhel Sanjay Ramakrishnan

Radhika Banka (@radhika_banka) 's Twitter Profile Photo

ABRA Trial : Huge strides in management of acute exacerbation of eosinophilic asthma/ COPD. 1 dose of Benralizumab far superior than oral steroids! Well done & congratulations Mona Bafadhel Sanjay Ramakrishnan ERS

ABRA Trial : Huge strides in management of acute exacerbation of eosinophilic asthma/ COPD. 1 dose of Benralizumab far superior than oral steroids! Well done &amp; congratulations <a href="/MonaBafadhel/">Mona Bafadhel</a> <a href="/SanjayResp/">Sanjay Ramakrishnan</a> <a href="/EuroRespSoc/">ERS</a>
Jacqui Pollington (@jacquipolington) 's Twitter Profile Photo

Time to unchain our COPD patients from the steroid burden of existing exacerbation treatments - powerful words from the amazing Mona Bafadhel #ERSCongress2024

Peter Wark (@peterwark1710) 's Twitter Profile Photo

Who is at most risk of exacerbating, those who are not using inhaled steroids overusing SABA, not attending primary care. A single dose treatment in hospital to prevent exacerbations. How long will it take us to stop using prednisone😔

James Dodd (@theotherdodd) 's Twitter Profile Photo

Let's say that again, and say it loud. DISEASE LABEL DOES NOT MATTER. Treat the endotype 🫁 ☑️ TH2 inflammation ❌ COPD ❌ Asthma #Treatabletraits #airwaysdisease #ERSCongress2024